-- Results indicate potential best-in-class RSV+hMPV±PIV3 combination vaccines, with the potential ability to re-vaccinate individuals previously receiving approved RSV vaccines to restore and broaden protection -- -- Increases in neutralizing antibodies of approximately 6-8 fold for RSV,...
Hence then, the article about clover announces positive phase i clinical data for rsv hmpv piv3 combination vaccines and for rsv re vaccination in older adults was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Clover Announces Positive Phase I Clinical Data for RSV-hMPV-PIV3 Combination Vaccines and for RSV Re-Vaccination in Older Adults )
Also on site :
- Japan vs Brazil: Live streaming, TV channel, kick-off time & where to watch International friendly
- Driver dies after car crashes and catches fire in Clarkson
- Military and civil drills in Lithuania as concerns over Russia increase